Capital Impact Advisors, LLC Pacific Biosciences Of California, Inc. Transaction History

Capital Impact Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.52 - $9.59 $116,184 - $316,537	-33,007 Reduced 22.67%	112,567 $422,000
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $728,334 - $1.26 Million	121,999 Added 517.49%	145,574 $1.43 Million
Q1 2023 May 23, 2023	BUY	$7.94 - $12.02 $82,639 - $125,104	10,408 Added 79.05%	23,575 $272,000
Q3 2022 Nov 21, 2022	BUY	$3.93 - $8.57 $51,746 - $112,841	13,167 New	13,167 $140,000
Q1 2021 May 18, 2021	SELL	$26.38 - $51.15 $7.91 Million - $15.3 Million	-300,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.5 - $28.5 $3.15 Million - $8.55 Million	300,000 New	300,000 $7.78 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.